Latanoprost/Timolol Viatris (Timolol Maleate, Latanoprost)

Timolol maleate blocks beta‑adrenergic receptors in the eye, decreasing aqueous humor production. Latanoprost, a prostaglandin analog, increases uveoscleral outflow of fluid. Together they achieve a greater reduction in intra‑ocular pressure than either agent alone.

The dosing regimen is determined by the prescribing ophthalmologist. Typically, one drop is instilled in the affected eye(s) once daily in the evening, but the exact schedule should follow the prescriber’s instructions.

Safety in pregnancy and lactation has not been established. The medication should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by the treating physician.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any required import documentation.

Compared with monotherapy, the combination offers additive pressure‑lowering effects, often achieving target pressure with a single drop rather than multiple agents. It may be preferred over separate prescriptions for patients needing both a prostaglandin analog and a beta‑blocker.

Store the eye‑drop bottles at room temperature, below 25 °C, in the original packaging. Protect from light and moisture, and keep the cap tightly closed when not in use.

The medication is applied as a sterile ophthalmic solution. Tilt the head back, pull down the lower eyelid to form a pocket, and place one drop into the conjunctival sac. Close the eye gently and avoid blinking excessively.

Serious adverse events include severe ocular inflammation, systemic bradycardia or hypotension, and allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience sudden vision loss, eye pain, or systemic symptoms like faintness.

Patients with known hypersensitivity to timolol, latanoprost, or any excipients should avoid the product. It is also contraindicated in individuals with severe asthma, chronic obstructive pulmonary disease, or certain cardiac conditions where beta‑blockade could be harmful.